Cargando…

Inequity in colorectal cancer treatment and outcomes: a population-based study

Several uncertainties surround optimal management of colorectal cancer. We investigated treatment patterns and factors influencing treatment receipt and mortality in routine clinical practice. We included 15 249 individuals, recorded by the National Cancer Registry (Ireland), with primary invasive c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carsin, A-E, Sharp, L, Cronin-Fenton, D P, Céilleachair, A Ó, Comber, H
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2008
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480963/ https://www.ncbi.nlm.nih.gov/pubmed/18594530 http://dx.doi.org/10.1038/sj.bjc.6604467

Ejemplares similares

Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy
por: Sharp, L, et al.
Publicado: (2012)

Reply: cost-effectiveness of population-based screening for colorectal cancer
por: Sharp, L, et al.
Publicado: (2013)

Clinical features of colorectal cancer before diagnosis: a population-based case–control study
por: Hamilton, W, et al.
Publicado: (2005)

Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997–2006
por: Cronin-Fenton, D P, et al.
Publicado: (2010)

Using resource modelling to inform decision making and service planning: the case of colorectal cancer screening in Ireland
por: Sharp, Linda, et al.
Publicado: (2013)

Treatment of 5-fluorouracil refractory metastatic colorectal cancer: an Australian population-based analysis
por: Damianovich, D, et al.
Publicado: (2007)

Population screening for colorectal cancer: the implications of an ageing population
por: Macafee, D A L, et al.
Publicado: (2008)

Factors prompting PSA-testing of asymptomatic men in a country with no guidelines: a national survey of general practitioners
por: Drummond, Frances J, et al.
Publicado: (2009)

Small but significant socioeconomic inequalities in axillary staging and treatment of breast cancer in the Netherlands
por: Aarts, M J, et al.
Publicado: (2012)

Colorectal cancer survivors: an investigation of symptom burden and influencing factors
por: O’Gorman, Claire, et al.
Publicado: (2018)

Socioeconomic inequalities in cancer survival in England after the NHS cancer plan
por: Rachet, B, et al.
Publicado: (2010)

P53 abnormalities and outcomes in colorectal cancer: a systematic review
por: Munro, A J, et al.
Publicado: (2005)

Age remains the major predictor of curative treatment non-receipt for localised prostate cancer: a population-based study
por: de Camargo Cancela, M, et al.
Publicado: (2013)

Factors affecting attitudes toward colorectal cancer screening in the primary care population
por: Taskila, T, et al.
Publicado: (2009)

Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis
por: Fluge, Ø, et al.
Publicado: (2009)

The impact of population-based faecal occult blood test screening on colorectal cancer mortality: a matched cohort study
por: Libby, G, et al.
Publicado: (2012)

Factors predicting hospital length-of-stay and readmission after colorectal resection: a population-based study of elective and emergency admissions
por: Kelly, Maria, et al.
Publicado: (2012)

Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers
por: Kim, Chang Gon, et al.
Publicado: (2016)

The mortality of colorectal cancer in relation to the initial symptom at presentation to primary care and to the duration of symptoms: a cohort study using medical records
por: Stapley, S, et al.
Publicado: (2006)

Antidepressant use and colorectal cancer risk: a Danish population-based case–control study
por: Cronin-Fenton, D P, et al.
Publicado: (2011)

Antidepressant use and colorectal cancer risk: a Danish population-based case–control study
por: Cronin-Fenton, D P, et al.
Publicado: (2011)

Inter-relationships between the economic and emotional consequences of colorectal cancer for patients and their families: a qualitative study
por: Ó Céilleachair, Alan, et al.
Publicado: (2012)

The importance of anaemia in diagnosing colorectal cancer: a case–control study using electronic primary care records
por: Hamilton, W, et al.
Publicado: (2008)

Screen-detected colorectal cancers are associated with an improved outcome compared with stage-matched interval cancers
por: Gill, M D, et al.
Publicado: (2014)

The impact of the Calman–Hine report on the processes and outcomes of care for Yorkshire's colorectal cancer patients
por: Morris, E, et al.
Publicado: (2006)

How much does it cost to care for survivors of colorectal cancer? Caregiver’s time, travel and out-of-pocket costs
por: Hanly, Paul, et al.
Publicado: (2013)

Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram
por: Lash, T L, et al.
Publicado: (2008)

Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases
por: Mekenkamp, L J M, et al.
Publicado: (2010)

Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer
por: Feliu, J, et al.
Publicado: (2010)

The impact of organisational external peer review on colorectal cancer treatment and survival in the Netherlands
por: Kilsdonk, M J, et al.
Publicado: (2014)

Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system
por: Bae, Jeong Mo, et al.
Publicado: (2017)

The Impact of Adjustment for Socioeconomic Status on Comparisons of Cancer Incidence between Two European Countries
por: Donnelly, David W., et al.
Publicado: (2013)

The expression of RUNX3 in colorectal cancer is associated with disease stage and patient outcome
por: Soong, R, et al.
Publicado: (2009)

Impact of deprivation and rural residence on treatment of colorectal and lung cancer
por: Campbell, N C, et al.
Publicado: (2002)

Concurrent irinotecan, oxaliplatin and UFT in first-line treatment of metastatic colorectal cancer: a Phase I study
por: Sheikh, H Y, et al.
Publicado: (2007)

Development of an imaging-guided CEA-pretargeted radionuclide treatment of advanced colorectal cancer: first clinical results
por: Schoffelen, R, et al.
Publicado: (2013)

Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients
por: Scartozzi, M, et al.
Publicado: (2012)

Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancer
por: Volkova, E, et al.
Publicado: (2011)

Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancer
por: Macarulla, T, et al.
Publicado: (2015)

Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy
por: Paré, L, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_oa52c9me1no0i5o9c2nio8iqin